Nascent Biotech Inc. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Nascent Biotech Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Nascent Biotech Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$376K, a 26.6% increase year-over-year.
  • Nascent Biotech Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$2.09M, a 2.22% decline year-over-year.
  • Nascent Biotech Inc. annual Operating Income (Loss) for 2023 was -$2.23M, a 3.44% decline from 2022.
  • Nascent Biotech Inc. annual Operating Income (Loss) for 2022 was -$2.16M, a 372% decline from 2021.
  • Nascent Biotech Inc. annual Operating Income (Loss) for 2021 was -$457K, a 67.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2.23M -$74.1K -3.44% Apr 1, 2023 Mar 31, 2024 10-K 2024-07-01
2022 -$2.16M -$1.7M -372% Apr 1, 2022 Mar 31, 2023 10-K 2024-07-01
2021 -$457K +$943K +67.4% Apr 1, 2021 Mar 31, 2022 10-K/A 2023-07-03
2020 -$1.4M +$2.05M +59.4% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-15
2019 -$3.45M -$2.08M -152% Apr 1, 2019 Mar 31, 2020 10-K 2021-07-08
2018 -$1.37M +$853K +38.4% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-22
2017 -$2.22M -$3.65M -256% Apr 1, 2017 Mar 31, 2018 10-K 2019-07-12
2016 $1.43M +$5.3M Apr 1, 2016 Mar 31, 2017 10-K 2018-06-29
2015 -$3.87M -$1.75M -82.3% Apr 1, 2015 Mar 31, 2016 10-K 2017-06-29
2014 -$2.12M -$1.55M -272% Apr 1, 2014 Mar 31, 2015 10-K 2016-07-14
2013 -$571K Apr 1, 2013 Mar 31, 2014 10-K 2015-07-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.